Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.
about
Use of Contraindicated Antiplatelet Medications in the Setting of Percutaneous Coronary Intervention: Insights From the Veterans Affairs Clinical Assessment, Reporting, and Tracking Program.Cangrelor for the treatment of arterial thrombosis: pharmacokinetics/pharmacodynamics and clinical data.Adherence to Cardiac Practice Guidelines in the Management of Non-ST-Elevation Acute Coronary Syndromes: A Systematic Literature Review.Long-term outcomes in high-risk patients with non-ST-segment elevation myocardial infarction.Indications, algorithms, and outcomes for coronary artery bypass surgery in patients with acute coronary syndromes.Novel antiplatelet agents in acute coronary syndrome.Role of Genetic Testing in Patients undergoing Percutaneous Coronary Intervention.Switching P2Y12-receptor inhibitors in patients with coronary artery disease.Platelet thrombin receptor antagonism with vorapaxar: pharmacology and clinical trial development.Antithrombotic agents for secondary prevention after acute coronary syndromes: A systematic review and network meta-analysis.Prasugrel Use Following PCI and Associated Patient Outcomes: Insights From the National VA CART Program.Antithrombotic therapy for patients with STEMI undergoing primary PCI.Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry.Precatheterization Use of P2Y12 Inhibitors in Non-ST-Elevation Myocardial Infarction Patients Undergoing Early Cardiac Catheterization and In-Hospital Coronary Artery Bypass Grafting: Insights From the National Cardiovascular Data Registry®.Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention.Contemporary Time Trends in Use of Antiplatelet Agents Among Patients with Acute Coronary Syndrome and Comorbid Diabetes Mellitus or Chronic Kidney Disease.Antiplatelet Therapy for Non-ST-Segment Elevation Myocardial Infarction in Complex "Real" Clinical Scenarios: A Consensus Document of the "Campania NSTEMI Study Group".Implementation and evaluation of a CYP2C19 genotype-guided antiplatelet therapy algorithm in high-risk coronary artery disease patients.An openEHR based approach to improve the semantic interoperability of clinical data registry.Restarting antiplatelet therapy after spontaneous intracerebral hemorrhage: Functional outcomesContemporary Prescription Patterns of Adenosine Diphosphate Receptor Inhibitors in Acute Coronary Syndrome
P2860
Q33432621-D61633FB-780E-4C67-803B-7B044B9B4ED1Q35569714-915C31CB-AC14-430F-A71A-B585B4AB1EE5Q36007741-74B6ECE4-72D4-443F-AD46-8074B5A64C11Q36706382-179049FB-F28D-4FC8-83F3-8C3CB5A562C4Q37481596-5BCE8284-9EF0-4083-BFE1-6F1429633E42Q38257119-0DBA95B6-9366-4341-AD05-F453F954DBA1Q38401281-E76ADD29-EFFF-4D38-BCBB-CD4338E2A16AQ38568711-B56BA4B9-C4FA-404A-98D2-5172FA768D40Q38592772-C835C2DD-3F0B-4C58-A347-7093602F41E4Q38742687-2D621CBF-7E57-401D-B1B7-335E8167B5F2Q38992769-C4A99C7C-70C8-4943-B305-88618177CBBEQ39147735-E3A3CA8E-6D0B-4552-8AFD-6487C97888CFQ41538436-36CF5098-F04A-4B24-A3A5-AD62FEE78431Q42373733-4A70A1DC-5E76-4FB6-AAFC-8329B16081ADQ47658855-A1E876D1-1DB4-418A-BC23-8895F10111B7Q50497419-F0CF843B-1523-4D4C-A285-97A2634054DEQ50864337-71F05C36-3256-48D6-BF75-C12522FFE38CQ50940254-FB1B1B79-35A3-446B-93A0-DC14703A2968Q52626030-1254D85B-57FB-4855-995D-04F6404CD71AQ56343937-E3012E8F-4A8C-4DD3-B0DF-6E1EF7B8CF03Q58574321-8B7BF247-DF38-4DF3-BDE4-B5E10A8A1503
P2860
Early clopidogrel versus prasugrel use among contemporary STEMI and NSTEMI patients in the US: insights from the National Cardiovascular Data Registry.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@ast
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@en
type
label
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@ast
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@en
prefLabel
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@ast
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@en
P2093
P2860
P356
P1476
Early clopidogrel versus prasu ...... Cardiovascular Data Registry.
@en
P2093
James Delemos
Matthew W Sherwood
S Andrew Peng
Stephen D Wiviott
Tracy Y Wang
P2860
P304
P356
10.1161/JAHA.114.000849
P577
2014-04-14T00:00:00Z